ArticleNature communications2026
Multimodal multitask deep learning for grading management system in non-small cell lung cancer.
Xinyue Liu, Fang Dai, Jiawei Dai, Huoqiang Wang, Qiang Li, Yaokai Wen, Haoyue Guo, Lishu Zhao, Hao Wang, Kandi Xu and 4 more
Abstract read
In one paragraphArticle in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Xinyue Liu *Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0003-4299-590X Jiawei DaiSJTU-Yale Joint Center for Biostatistics and Data Science, Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.ORCID http://orcid.org/0000-0003-3806-5160 Huoqiang WangDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Qiang LiDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Yaokai WenDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Haoyue GuoDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0001-7021-4002 Lishu ZhaoDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Hao WangDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Kandi XuDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Maotao WengDepartment of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Siqiong YaoSJTU-Yale Joint Center for Biostatistics and Data Science, Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. yaosiqiong@sjtu.edu.cn.ORCID http://orcid.org/0000-0001-6968-1586 Hui LuSJTU-Yale Joint Center for Biostatistics and Data Science, Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. huilu@sjtu.edu.cn.ORCID http://orcid.org/0000-0001-8347-0830 Yayi HeDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China. yayi.he@tongji.edu.cn.ORCID http://orcid.org/0000-0002-2878-8595 Funding
National Natural Science Foundation of China (National Science Foundation of China) 52272281National Natural Science Foundation of China (National Science Foundation of China) 62406191
6 · The paper itselfAbstract
Accurate histologic subtyping, tumor node metastasis classification (TNM) staging and prognostic assessment are central to clinical management of non-small cell lung cancer (NSCLC), but remain challenging because of tumor heterogeneity, limited biomarker performance and diagnostic uncertainty. Here we show that a multimodal, multi-task deep learning scoring system (MM-DLS), integrating pretreatment PET/CT images with clinical variables, enables non-invasive prediction of NSCLC subtype, stage and survival risk. We develop and validate MM-DLS in 4,164 patients from multiple centres. In the external validation cohort, MM-DLS achieves area under the receiver operating characteristic curve values of 0.86 for histologic subtype classification and 0.86, 0.86, and 0.88 for stages I-II, III, and IV, respectively. The model also shows consistently strong discrimination for 1-, 3-, and 5-year survival across treatment regimens. These results indicate that MM-DLS provides an integrated framework for subtype prediction, staging, and prognostic stratification in NSCLC.
Indexed as
Carcinoma, Non-Small-Cell LungDeep LearningLung NeoplasmsAgedFemaleHumansMaleNeoplasm GradingNeoplasm StagingPositron Emission Tomography Computed TomographyPrognosisROC Curve
Identifiers
PMID42297835
PMCPMC13416042
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390